Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Haas

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis and Related Disorders|December 23, 2019
Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumabTjalf Ziemssen, Michael Lang, Björn Tackenberg, et al.
Deutsches Arzteblatt International|July 28, 2009
Multiple sclerosis registry in Germany: results of the extension phase 2005/2006Peter Flachenecker, Kristin Stuke, Wolfgang Elias, et al.
The Journal of Comparative Neurology|July 10, 2023
Organization of descending neurons in the brain of the desert locustErich M Staudacher, Michel-Leon Cigan, Felix Wenz, et al.
Journal of Neurology|July 25, 2009
Symptomatology of MS: results from the German MS RegistryKristin Stuke, Peter Flachenecker, Uwe K Zettl, et al.
Plos One|May 2, 2020
Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims dataChristoph Ohlmeier, Holger Gothe, Judith Haas, et al.
Fortschritte Der Neurologie-Psychiatrie|October 16, 2020
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]Peter Flachenecker, Kerstin Eichstädt, Klaus Berger, et al.
Fortschritte Der Neurologie-Psychiatrie|July 28, 2020
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]Peter Flachenecker, Kerstin Eichstädt, Klaus Berger, et al.
Therapeutic Advances in Neurological Disorders|October 14, 2021
Treatment patterns in pediatric patients with multiple sclerosis in Germany-a nationwide claim-based analysisNiklas Frahm, Melanie Peters, Jörg Bätzing, et al.
European Journal of Neurology|July 9, 2021
Prevalence of pediatric multiple sclerosis in Germany: A nationwide population-based analysisNiklas Frahm, Melanie Peters, Jörg Bätzing, et al.
Multiple Sclerosis and Related Disorders|August 11, 2018
Decreasing longitudinal use of glucocorticosteroids in multiple sclerosisDavid Ellenberger, Kerstin Eichstädt, Peter Flachenecker, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|December 23, 2019
Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumabTjalf Ziemssen, Michael Lang, Björn Tackenberg, et al.
Deutsches Arzteblatt International|July 28, 2009
Multiple sclerosis registry in Germany: results of the extension phase 2005/2006Peter Flachenecker, Kristin Stuke, Wolfgang Elias, et al.
The Journal of Comparative Neurology|July 10, 2023
Organization of descending neurons in the brain of the desert locustErich M Staudacher, Michel-Leon Cigan, Felix Wenz, et al.
Journal of Neurology|July 25, 2009
Symptomatology of MS: results from the German MS RegistryKristin Stuke, Peter Flachenecker, Uwe K Zettl, et al.
Plos One|May 2, 2020
Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims dataChristoph Ohlmeier, Holger Gothe, Judith Haas, et al.
Fortschritte Der Neurologie-Psychiatrie|October 16, 2020
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]Peter Flachenecker, Kerstin Eichstädt, Klaus Berger, et al.
Fortschritte Der Neurologie-Psychiatrie|July 28, 2020
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]Peter Flachenecker, Kerstin Eichstädt, Klaus Berger, et al.
Therapeutic Advances in Neurological Disorders|October 14, 2021
Treatment patterns in pediatric patients with multiple sclerosis in Germany-a nationwide claim-based analysisNiklas Frahm, Melanie Peters, Jörg Bätzing, et al.
European Journal of Neurology|July 9, 2021
Prevalence of pediatric multiple sclerosis in Germany: A nationwide population-based analysisNiklas Frahm, Melanie Peters, Jörg Bätzing, et al.
Multiple Sclerosis and Related Disorders|August 11, 2018
Decreasing longitudinal use of glucocorticosteroids in multiple sclerosisDavid Ellenberger, Kerstin Eichstädt, Peter Flachenecker, et al.
Pageof 5